Chemotherapy Plus Bevacizumab Promising in Advanced TNBC

A triplet regimen including paclitaxel, capecitabine, and bevacizumab showed efficacy and safety in women with advanced triple-negative breast cancer.

Source: CancerNetwork - July 18, 2016 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer News Triple-Negative Breast Cancer Source Type: news